Coronavirus | MahaRERA extends completion deadlines of real estate projects by 3 months

Real estate developers welcome the move

Vandana Ramnani

In view of the country-wide lockdown on account of the novel coronavirus, or COVID-19, pandemic, the Maharashtra Real Estate Regulatory Authority (MahaRERA) has decided to extend the validity period for registration of real estate projects, whose date of completion or for that matter extended completion date gets over on or after March 15, for a period of three months, it said in a statement

“MahaRERA shall accordingly issue project registration certificates, with revised timelines for such projects, at the earliest,” it said.

The authority has also extended the time limits of all statutory compliances in accordance with the Real Estate (Regulation and Development) Act, 2016 that were due in March, April and May to June 30.

It noted that due to the lockdowns, the supply chains for obtaining construction material have been disrupted and labour force may have migrated back to their home states. Due to these circumstances, real estate projects across Maharashtra will take some time to restart work.

In order to aid government efforts in controlling the damage of COVID-19 and ensure that completion of MahaRERA registered projects does not get adversely affected, it has been decided to issue this order, it said.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show

Shishir Baijal, CMD, Knight Frank India, said the “deferment of deadline by the MahaRERA is a good decision given the current conditions. The government has given some respite to the residential real estate sector, which will be feeling the impact of this lockdown. While we hope that this crisis will be over soon, steps such as these will help reduce the severity of the lockdown in short term.”

Follow our full coverage here…